Celltrion Healthcare Co., Ltd. (KOSDAQ:A091990) announces a share repurchase program. Under the program, the company will repurchase up to 1,320,000 shares. The purpose of the share repurchase program is to stabilize the share price and enhance shareholder value.

The repurchase program will continue until December 17, 2023. As of November 8, 2023, the company had 7,198,854 shares in treasury within scope available for dividend and had 382,497 shares in treasury through other acquisition.